US5151439A
(en)
*
|
1990-05-04 |
1992-09-29 |
American Cyanamid Company |
Substituted 5-(2-((2-aryl-2-hydroxyethyl)amino)propyl)-1,3-benzodioxoles
|
US5089514A
(en)
*
|
1990-06-14 |
1992-02-18 |
Pfizer Inc. |
3-coxazolyl [phenyl, chromanyl or benzofuranyl]-2-hydroxypropionic acid derivatives and analogs as hypoglycemic agents
|
TW222626B
(no)
|
1991-07-22 |
1994-04-21 |
Pfizer |
|
US5498621A
(en)
*
|
1992-05-01 |
1996-03-12 |
Pfizer Inc. |
Oxazolidinedione hypoglycemic agents
|
RU2134686C1
(ru)
*
|
1992-07-03 |
1999-08-20 |
Смитклайн Бичам П.Л.С. |
Гетероциклическое соединение, или его таутомерная форма, и/или фармацевтически приемлемая соль, и/или фармацевтически приемлемый сольват, фармацевтическая композиция, снижающая содержание глюкозы в крови, способ лечения и/или профилактики гипергликемии
|
US5232945A
(en)
*
|
1992-07-20 |
1993-08-03 |
Pfizer Inc. |
3-aryl-2-hydroxypropionic acid derivatives and analogs as antihypertensives
|
GB9225386D0
(en)
*
|
1992-12-04 |
1993-01-27 |
Smithkline Beecham Plc |
Novel compounds
|
GB9311661D0
(en)
*
|
1993-06-05 |
1993-07-21 |
Smithkline Beecham Plc |
Novel compounds
|
GB9311644D0
(en)
*
|
1993-06-05 |
1993-07-21 |
Smithkline Beecham Plc |
Novel compounds
|
GB9315148D0
(en)
*
|
1993-07-22 |
1993-09-08 |
Smithkline Beecham Plc |
Novel compounds
|
GB9326171D0
(en)
*
|
1993-12-22 |
1994-02-23 |
Smithkline Beecham Plc |
Novel compounds
|
WO1996004261A1
(en)
*
|
1994-07-29 |
1996-02-15 |
Smithkline Beecham Plc |
Benzoxazoles and pryridine derivatives useful in the treatment of the type ii diabetes
|
US5827865A
(en)
*
|
1995-03-09 |
1998-10-27 |
Smithkline Beecham P.L.C. |
Heterocyclic compounds as pharmaceutical
|
GB9604242D0
(en)
|
1996-02-28 |
1996-05-01 |
Glaxo Wellcome Inc |
Chemical compounds
|
CN1104413C
(zh)
*
|
1996-04-04 |
2003-04-02 |
三共株式会社 |
苯基烷基羧酸衍生物
|
CA2259487A1
(en)
|
1996-07-01 |
1998-01-08 |
Margaret Mary Faul |
Hypoglycemic and hypolipidemic compounds
|
EP1019378B1
(en)
*
|
1996-07-01 |
2004-09-29 |
Eli Lilly And Company |
Hypoglycemic and hypolipidemic compounds
|
RU2174121C2
(ru)
*
|
1996-08-19 |
2001-09-27 |
Джапан Тобакко Инк. |
Производные пропионовой кислоты и фармацевтическая композиция на их основе
|
US6090839A
(en)
*
|
1996-12-23 |
2000-07-18 |
Merck & Co., Inc. |
Antidiabetic agents
|
US6160000A
(en)
*
|
1996-12-23 |
2000-12-12 |
Merck & Co., Inc. |
Antidiabetic agents based on aryl and heteroarylacetic acids
|
WO1998028254A1
(fr)
*
|
1996-12-24 |
1998-07-02 |
Nippon Chemiphar Co., Ltd. |
Derives d'acide propionique
|
AU8539298A
(en)
|
1997-06-18 |
1999-01-04 |
Smithkline Beecham Plc |
Treatment of diabetes with thiazolidinedione and sulphonylurea
|
DE69815008T2
(de)
*
|
1997-09-19 |
2004-04-01 |
Ssp Co., Ltd. |
Alfa-substituierte Phenylpropionsäurederivate und diese enthaltende Arzneimittel
|
RU2176999C2
(ru)
|
1997-10-02 |
2001-12-20 |
Санкио Компани, Лимитед |
Производные амидокарбоновой кислоты, фармацевтическая композиция на их основе и способ снижения глюкозы в крови
|
HUP0101110A3
(en)
|
1997-10-27 |
2002-06-28 |
Reddys Lab Ltd Dr |
Bicyclic compounds, process for their preparation and pharmaceutical compositions containing them
|
US6369067B1
(en)
|
1997-10-27 |
2002-04-09 |
Dr. Reddy's Research Foundation |
Monocyclic compounds and their use in medicine: process for their preparation and pharmaceutical compositions containing them
|
WO1999016758A1
(en)
*
|
1997-10-27 |
1999-04-08 |
Dr. Reddy's Research Foundation |
Novel heterocyclic compounds and their use in medicine, process for their preparation and pharmaceutical compositions containing them
|
US6265401B1
(en)
|
1997-10-27 |
2001-07-24 |
Reddy-Cheminor, Inc. |
Bicyclic compounds and their use in medicine, process for their preparation and pharmaceutical compositions containing them
|
US6444816B1
(en)
|
1997-10-27 |
2002-09-03 |
Dr. Reddy's Research Foundation |
Fused 7-oxo-pyrimidinyl compounds, preparation, composition and use thereof
|
EP1049684A1
(en)
*
|
1997-10-27 |
2000-11-08 |
Dr. Reddy's Research Foundation |
Novel tricyclic compounds and their use in medicine; process for their preparation and pharmaceutical compositions containing them
|
US6440961B1
(en)
|
1997-10-27 |
2002-08-27 |
Dr. Reddy's Research Foundation |
Tricyclic compounds and their use in medicine: process for their preparation and pharmaceutical compositions containing them
|
EP1051403A1
(en)
*
|
1998-01-29 |
2000-11-15 |
Dr. Reddy's Research Foundation |
Novel alkanoic acids and their use in medicine, process for their preparation and pharmaceutical compositions containing them
|
US6166069A
(en)
*
|
1998-05-12 |
2000-12-26 |
American Home Products Corporation |
Phenyl oxo-acetic acids useful in the treatment of insulin resistance and hyperglycemia
|
AU3791799A
(en)
*
|
1998-05-12 |
1999-11-29 |
American Home Products Corporation |
Phenyl oxo-acetic acids useful in the treatment of insulin resistance and hyperglycemia
|
EP1082313A1
(en)
*
|
1998-05-27 |
2001-03-14 |
Dr. Reddy's Research Foundation |
Bicyclic compounds, process for their preparation and pharmaceutical compositions containing them
|
MA26634A1
(fr)
|
1998-06-04 |
2004-12-20 |
Astra Ab |
Nouveaux derives de l'acide 3-aryl propionique et analogues
|
SE9801992D0
(sv)
*
|
1998-06-04 |
1998-06-04 |
Astra Ab |
New 3-aryl-2-hydroxypropionic acid derivative I
|
WO1999065897A1
(en)
|
1998-06-19 |
1999-12-23 |
Chiron Corporation |
Inhibitors of glycogen synthase kinase 3
|
US7045519B2
(en)
|
1998-06-19 |
2006-05-16 |
Chiron Corporation |
Inhibitors of glycogen synthase kinase 3
|
GB9817118D0
(en)
|
1998-08-07 |
1998-10-07 |
Glaxo Group Ltd |
Pharmaceutical compounds
|
AU5443499A
(en)
*
|
1998-08-27 |
2000-03-21 |
Ono Pharmaceutical Co. Ltd. |
Carboxylic acid derivatives and drugs containing the same as the active ingredient
|
US6589969B1
(en)
|
1998-10-16 |
2003-07-08 |
Ono Pharmaceutical Co., Ltd. |
Carboxylic acid derivatives and drugs containing the same as the active ingredient
|
EP1813273A1
(en)
|
1998-11-12 |
2007-08-01 |
Smithkline Beecham Plc |
Pharmaceutical composition for modified release of an insulin sensitiser and another antidiabetic agent
|
DZ2937A1
(fr)
|
1998-11-12 |
2004-03-15 |
Smithkline Beecham Plc |
Compositions nouvelles de sensibilidants à l'insuline.
|
WO2000063189A1
(en)
*
|
1999-04-16 |
2000-10-26 |
Novo Nordisk A/S |
Crystalline r- guanidines, arginine or (l) -arginine (2s) -2- ethoxy -3-{4- [2-(10h -phenoxazin -10-yl)ethoxy]phenyl}propanoate
|
IL145958A0
(en)
*
|
1999-04-16 |
2002-07-25 |
Reddy Research Foundation |
Polymorphic form of arginine salt of (2s)-3-[4-[2-phenoxazin-10-yl)ethoxy] phenyl]2-ethoxypropanoic acid, processes for the preparation thereof and pharmaceutical compositions containing the same
|
US6528507B1
(en)
|
1999-04-16 |
2003-03-04 |
Dr. Reddy's Laboratories Limited |
Polymorphic forms of an antidiabetic agent: process for their preparation and a pharmaceutical composition containing them
|
US6972294B1
(en)
|
1999-04-20 |
2005-12-06 |
Novo Nordisk, A/S |
Compounds, their preparation and use
|
EP1189889B1
(en)
*
|
1999-06-04 |
2003-12-17 |
Elan Pharma International Limited |
Compositions and methods for inhibiting cell death
|
WO2001011072A1
(en)
*
|
1999-08-05 |
2001-02-15 |
Novo Nordisk A/S |
Process for the preparation of substituted 3-phenyl-propanoic acid esters and substituted 3-phenyl-propanoic acids
|
US6541495B1
(en)
|
1999-08-27 |
2003-04-01 |
Pfizer |
Carboxylic acid derivatives as inhibitors of hyperproliferation diseases
|
EP1212304A2
(en)
|
1999-08-27 |
2002-06-12 |
Eli Lilly And Company |
Hypoglycemic sulfonyl pyrazolones and pyrazolines
|
ES2204684T3
(es)
|
1999-08-27 |
2004-05-01 |
Eli Lilly And Company |
Derivados de biaril-oxa(tia)zol y su uso como modulares de ppar.
|
DZ3279A1
(fr)
*
|
2000-01-19 |
2001-07-26 |
Cadila Healthcare Ltd |
Nouveaux composes ayant des activites hypolipidemiques et hypocholesterolemiques, procede pour leur preparation et compositions pharmaceutiques les contenant
|
US6555577B1
(en)
|
2000-01-28 |
2003-04-29 |
Novo Nordisk A/S |
Compounds, their preparation and use
|
GB0002667D0
(en)
*
|
2000-02-04 |
2000-03-29 |
Glaxo Group Ltd |
medicamesnts
|
US6509374B2
(en)
|
2000-04-17 |
2003-01-21 |
Novo Nordisk A/S |
Compounds, their preparation and use
|
EP1280783A2
(en)
*
|
2000-05-12 |
2003-02-05 |
Ortho-McNeil Pharmaceutical, Inc. |
Methods of treatment using benzoxazinones as peroxisome proliferator activated receptor gamma modulators
|
US6908908B2
(en)
|
2000-05-12 |
2005-06-21 |
Ortho-Mcneil Pharmaceutical, Inc. |
Biologically active 4H-benzo [1,4] oxazin-3-ones
|
ES2288957T3
(es)
|
2000-05-12 |
2008-02-01 |
Ortho-Mcneil Pharmaceutical, Inc. |
4h-benzo(1.4)oxazin-3-ina biologicamente activas.
|
AU2001259747A1
(en)
*
|
2000-05-12 |
2001-11-26 |
Ortho-Mcneil Pharmaceutical, Inc. |
Novel benzoxazinones as peroxisome proliferator activated receptor gamma modulators and method of treatment
|
GB0014969D0
(en)
|
2000-06-19 |
2000-08-09 |
Smithkline Beecham Plc |
Novel method of treatment
|
US7176224B2
(en)
*
|
2000-08-23 |
2007-02-13 |
Eli Lilly And Company |
Oxazolyl-aryloxyacetic acid derivatives and their use as PPAR agonists
|
US6982278B2
(en)
*
|
2000-08-23 |
2006-01-03 |
Eli Lilly And Company |
Oxazolyl-aryloxyacetic acid derivatives and their use as ppar agonists
|
PL360744A1
(en)
*
|
2000-08-23 |
2004-09-20 |
Eli Lilly And Company |
Oxazolyl-arylpropionic acid derivatives and their use as ppar agonists
|
HU230224B1
(hu)
|
2001-05-15 |
2015-10-28 |
F. Hoffmann-La Roche Ag |
Karbonsavval helyettesített oxazol-származékok, PPAR-alfa- és -gamma-aktivátorként diabétesz kezelésére történő felhasználásra
|
CN1578659A
(zh)
*
|
2001-06-07 |
2005-02-09 |
伊莱利利公司 |
过氧化物酶体增殖剂激活的受体(ppar)的调节剂
|
BR0210190A
(pt)
|
2001-06-07 |
2004-04-06 |
Lilly Co Eli |
Moduladores de receptores ativados de proliferador de peroxissomo
|
US6987123B2
(en)
*
|
2001-07-26 |
2006-01-17 |
Cadila Healthcare Limited |
Heterocyclic compounds, their preparation, pharmaceutical compositions containing them and their use in medicine
|
US20030055076A1
(en)
*
|
2001-07-30 |
2003-03-20 |
Lone Jeppesen |
Novel compounds, their preparation and use
|
US7067530B2
(en)
|
2001-07-30 |
2006-06-27 |
Novo Nordisk A/S |
Compounds, their preparation and use
|
US6869967B2
(en)
|
2001-07-30 |
2005-03-22 |
Novo Nordisk A/S |
Peroxisome proliferator-activated receptor (PPAR) active vinyl carboxylic acid derivatives
|
CN1330641C
(zh)
*
|
2001-08-10 |
2007-08-08 |
日本化学医药株式会社 |
过氧化物酶体增殖剂响应受体δ活化剂
|
US20030171377A1
(en)
*
|
2001-08-29 |
2003-09-11 |
Bigge Christopher Franklin |
Antidiabetic agents
|
FR2830012B1
(fr)
*
|
2001-09-21 |
2003-10-31 |
Servier Lab |
Nouveaux derives heterocycliques, leur procede de preparation et les compositions pharamaceutiques qui les contiennent
|
JP4276074B2
(ja)
*
|
2001-10-12 |
2009-06-10 |
日本ケミファ株式会社 |
ペルオキシソーム増殖剤応答性受容体δの活性化剤
|
US7220877B2
(en)
|
2001-10-17 |
2007-05-22 |
Novo Nordisk A/S |
Compounds, their preparation and use
|
SE0104333D0
(sv)
|
2001-12-19 |
2001-12-19 |
Astrazeneca Ab |
Therapeutic agents
|
ITRM20020016A1
(it)
*
|
2002-01-15 |
2003-07-15 |
Sigma Tau Ind Farmaceuti |
Derivati di acidi fenil(alchil)carbossilici e derivati fenilalchileterociclici dionici, loro uso come medicamenti ad attivita' ipoglicemizza
|
US6716842B2
(en)
|
2002-04-05 |
2004-04-06 |
Warner-Lambert Company, Llc |
Antidiabetic agents
|
PL374818A1
(en)
*
|
2002-07-03 |
2005-10-31 |
F.Hoffmann-La Roche Ag |
Oxazole derivatives and their use as insulin sensitizers
|
WO2004011446A1
(en)
*
|
2002-07-26 |
2004-02-05 |
Bayer Pharmaceuticals Corporation |
Indane, dihydrobenzofuran, and tetrahydronaphthalene carboxylic acid derivatives and their use as antidiabetics
|
US8268352B2
(en)
*
|
2002-08-05 |
2012-09-18 |
Torrent Pharmaceuticals Limited |
Modified release composition for highly soluble drugs
|
US8216609B2
(en)
*
|
2002-08-05 |
2012-07-10 |
Torrent Pharmaceuticals Limited |
Modified release composition of highly soluble drugs
|
DK1537091T3
(da)
*
|
2002-08-30 |
2010-11-08 |
Hoffmann La Roche |
Hidtil ukendte 2-arylthiazolforbindelser som PPAR alpha- og PPAR gamma-agonister
|
DE60309719T2
(de)
*
|
2002-09-12 |
2007-09-20 |
F. Hoffmann-La Roche Ag |
N-substituierte-1h-indol-5-propansäure verbindungen als ppar-agonisten zur behandlung von diabetis
|
TWI343915B
(en)
|
2002-10-07 |
2011-06-21 |
Hoffmann La Roche |
Chirale ppar agonists
|
PL210871B1
(pl)
*
|
2002-11-08 |
2012-03-30 |
Hoffmann La Roche |
Pochodne oksazolu, sposób ich wytwarzania, środki farmaceutyczne i zastosowanie pochodnych oksazolu
|
RS20050426A
(en)
*
|
2002-11-15 |
2008-04-04 |
Cadila Healthcare Limited, |
Substituted aralkyl derivatives
|
JP4384052B2
(ja)
*
|
2002-11-25 |
2009-12-16 |
エフ.ホフマン−ラ ロシュ アーゲー |
インドリル誘導体
|
US7816385B2
(en)
|
2002-12-20 |
2010-10-19 |
High Point Pharmaceuticals, Llc |
Dimeric dicarboxylic acid derivatives, their preparation and use
|
JP2006520755A
(ja)
*
|
2003-02-14 |
2006-09-14 |
イーライ リリー アンド カンパニー |
Pparモジュレータとしてのスルホンアミド誘導体
|
US20050182125A1
(en)
*
|
2003-05-16 |
2005-08-18 |
Ambit Biosciences Corporation |
Pyrrole compounds and uses thereof
|
US20040242673A1
(en)
*
|
2003-05-16 |
2004-12-02 |
Ambit Biosciences Corporation |
Heterocyclic compounds and uses thereof
|
US20040248972A1
(en)
*
|
2003-05-16 |
2004-12-09 |
Ambit Biosciences Corporation |
Compounds and uses thereof
|
EP1627873A4
(en)
|
2003-05-29 |
2007-12-05 |
New Ind Res Organization |
BENZOFURAN-BASED COMPOUND AND MEDICINAL COMPOSITION CONTAINING THE SAME
|
JP2005008631A
(ja)
*
|
2003-05-29 |
2005-01-13 |
New Industry Research Organization |
ベンゾフラン化合物、およびそれを含有してなる医薬組成物
|
GB0314131D0
(en)
*
|
2003-06-18 |
2003-07-23 |
Astrazeneca Ab |
Therapeutic agents
|
GB2414294B
(en)
|
2004-05-20 |
2006-08-02 |
Teraview Ltd |
Apparatus and method for investigating a sample
|
KR101233223B1
(ko)
*
|
2004-12-21 |
2013-02-14 |
제이엔씨 석유 화학 주식회사 |
크로만환을 가지는 액정 화합물, 액정 조성물 및 이 액정조성물을 함유하는 액정 표시소자
|
JPWO2007004733A1
(ja)
*
|
2005-07-06 |
2009-01-29 |
日本ケミファ株式会社 |
ペルオキシソーム増殖剤活性化受容体δの活性化剤
|
WO2007087505A2
(en)
|
2006-01-25 |
2007-08-02 |
Wellstat Therapeutics Corporation |
Compounds for the treatment of metabolic disorders
|
MX2008013292A
(es)
*
|
2006-04-18 |
2008-11-14 |
Nippon Chemiphar Co |
Agente activador para el receptor ? activado por el proliferador de peroxisoma.
|
DE102006021878A1
(de)
|
2006-05-11 |
2007-11-15 |
Sanofi-Aventis |
Phenylamino-benzoxazol substituierte Carbonsäuren, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
|
BRPI0911197A2
(pt)
*
|
2008-04-15 |
2015-10-13 |
Nippon Chemiphar Co |
composto, ativador de receptor ativado pelo proliferador de peroxissoma, e, medicamento para o tratamento e /ou profilaxia de uma doença.
|
CN102648025A
(zh)
*
|
2009-07-07 |
2012-08-22 |
火星工程有限公司 |
爆震波防止器
|
RU2012109545A
(ru)
*
|
2009-08-14 |
2013-09-20 |
Серенис Терапьютикс С.А. |
Использование лигандов ppar дельта для лечения или предотвращения воспалений или заболеваний, связанных с метаболизмом/выработкой энергии
|
GB201002243D0
(en)
*
|
2010-02-10 |
2010-03-31 |
Argenta Therapeutics Ltd |
Respiratory disease treatment
|
CN101941950B
(zh)
*
|
2010-08-05 |
2012-12-26 |
上海交通大学 |
2-取代苯并[d]噁唑-5-丙酸化合物及其制备和应用
|
NZ612804A
(en)
|
2011-01-31 |
2015-09-25 |
Cadila Healthcare Ltd |
Treatment for lipodystrophy
|
EA201592020A1
(ru)
|
2013-04-22 |
2016-05-31 |
Кадила Хелзкэр Лимитед |
Новая композиция для неалкогольной жировой болезни печени (нажбп)
|
MX2015016403A
(es)
|
2013-05-30 |
2016-04-11 |
Cadila Healthcare Ltd |
Proceso para la preparacion de pirroles que tienen actividad hipolipidemica e hipocolesterolemica.
|
TW201513857A
(zh)
|
2013-07-05 |
2015-04-16 |
Cadila Healthcare Ltd |
協同性組成物
|
IN2013MU02470A
(no)
|
2013-07-25 |
2015-06-26 |
Cadila Healthcare Ltd |
|
WO2015033357A2
(en)
|
2013-09-06 |
2015-03-12 |
Cadila Healthcare Limited |
An improved process for the preparation of pyrrole derivatives
|
WO2016022446A1
(en)
|
2014-08-08 |
2016-02-11 |
Merck Sharp & Dohme Corp. |
[5,6]-fused bicyclic antidiabetic compounds
|
WO2017064635A2
(en)
|
2015-10-14 |
2017-04-20 |
Cadila Healthcare Limited |
Pyrrole compound, compositions and process for preparation thereof
|
JP6840853B2
(ja)
|
2016-12-09 |
2021-03-10 |
カディラ・ヘルスケア・リミテッド |
原発性胆汁性胆管炎の治療
|